Key Players
Competitive Landscape
Competition in acrolein follows the service being bought. An integrated methionine producer depends on its own precursor unit, an independent converter needs a merchant contract with dispatch quantities it can receive, a treatment operator needs help applying the chemical within an existing system, and a laboratory needs an analytical product with the right documentation. These needs divide the market into separate groups of suppliers.
Dependable operation and consistent product quality will shape competition through 2036. A different production route gains relevance when it supplies repeatable material under a workable commercial arrangement, but an announced project or a successful reaction does not secure continuing supply. Repeat orders will follow sustained plant operation and deliveries that match customer campaigns.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| June 2025: Evonik announced maintenance at its methionine and precursor facilities in Singapore and Antwerp, with shutdowns of six to seven weeks at each site. [2] | Connected production units need coordinated operating schedules. | Catalyst changes and plant improvements require planned interruptions. | Agree delivery cover and qualify continuity arrangements before a shutdown. |
| April 2025: Adisseo reported that its 150,000-tonne-a-year powder methionine project in Quanzhou was under construction and on schedule. [1] | Investment in downstream conversion can add precursor requirements. | Recurring demand depends on commissioning and the supply arrangement chosen. | Plan supply around verified project stages and separate captive from external supply. |
Source: Future Market Insights, Acrolein Market Report, 2026-2036.
The two disclosures have different effects on demand. Maintenance changes the delivery calendar of existing production, while construction creates a future requirement that depends on commissioning. Suppliers that understand both can make more dependable commitments to customers.
How are key market participants positioned in the acrolein market?
Zhejiang NHU offers acrolein to the merchant market and also consumes the chemical itself. [4] Evonik and Adisseo influence precursor requirements through methionine production, [2][1] Baker Hughes is active through acrolein treatment services and Merck supplies laboratory products. These roles reflect positions in different applications, not a global share ranking.
What qualification or purchasing requirements matter most to prospective buyers?
Industrial converters need a specification suited to their reaction and purification stages, delivery equipment that fits the receiving site and an agreed response to maintenance interruptions. Exposure controls stay relevant under NIOSH guidance. [5] Laboratory buyers focus on product identity and certificates, and treatment customers also need application support.
Which product or application capabilities distinguish the leading companies?
Zhejiang NHU combines propylene oxidation acrolein with bulk delivery formats. Evonik's precursor operations and Adisseo's methionine programmes place them in the integrated chemical chain. Baker Hughes offers MAGNACIDE B acrolein chemical services for bacteria management, and Merck's Sigma-Aldrich products serve analytical procurement. The suppliers are differentiated by their ability to support a specific conversion, treatment or laboratory purpose with consistent material and the service it needs.
How does geographic reach differ among the key market players?
Zhejiang NHU produces acrolein in Shandong, which connects Chinese manufacturing with internal and external chemical users. Evonik's maintenance programme covers Singapore and Antwerp, and Adisseo's powder methionine construction is in Quanzhou. Location matters through the operating calendar and the delivery route, so customers served from an export site must coordinate transit time and approved stock with that site's planned interruptions.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Zhejiang NHU | Acrolein producer and merchant supplier, also an internal user. | Supplies gas phase propylene oxidation acrolein in tanker trucks and ISO tanks. [4] |
| Evonik Industries | Integrated methionine and precursor participant. | Announced maintenance and technical measures at its Singapore and Antwerp facilities in June 2025. [2] |
| Adisseo | Methionine producer with powder and liquid manufacturing programmes. | Reported its 150,000-tonne-a-year Quanzhou powder methionine project under construction in April 2025. [1] |
| Baker Hughes | Application service provider for industrial bacteria management. | Offers MAGNACIDE B acrolein chemical services. |
| Merck | Laboratory and analytical chemical supplier. | Supplies acrolein analytical products through Sigma-Aldrich. |
Research Methodology
The acrolein market assessment was conducted using primary interviews and secondary literature analysis combined with top-down data triangulation to validate market size, segment shares, and competitive positioning.
